Trends in Management and Outcomes of ST-Elevation Myocardial Infarction in Patients With End-Stage Renal Disease in the United States
- 30 January 2015
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 115 (8), 1033-1041
- https://doi.org/10.1016/j.amjcard.2015.01.529
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Trends in Incidence, Management, and Outcomes of Cardiogenic Shock Complicating ST‐Elevation Myocardial Infarction in the United StatesJournal of the American Heart Association, 2014
- Pulmonary Embolism in Patients with CKD and ESRDClinical Journal of the American Society of Nephrology, 2012
- Quality of Care and Outcomes Among Patients With Acute Myocardial Infarction by Level of Kidney Function at Admission: Report From the Get With The Guidelines Coronary Artery Disease ProgramClinical Cardiology, 2012
- Twenty-Two–Year Trends in Incidence of Myocardial Infarction, Coronary Heart Disease Mortality, and Case Fatality in 4 US Communities, 1987–2008Circulation, 2012
- Declining Length of Stay for Patients Hospitalized with AMI: Impact on Mortality and ReadmissionsAmerican Journal Of Medicine, 2010
- Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney DiseaseCirculation, 2010
- Patients with end-stage renal disease and acute myocardial infarction have poor short-term outcomes despite modern cardiac intensive careCoronary Artery Disease, 2008
- Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplastyEuropean Heart Journal, 2004
- Impact of Renal Insufficiency in Patients Undergoing Primary Angioplasty for Acute Myocardial InfarctionCirculation, 2003
- Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trialsThe Lancet, 2003